Print this page
-
Web-based Coping and Communication Skills Intervention for Women who are newly diagnosed with Gynecological cancer: A Pilot Study
Protocol: 131908Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Ovary
Cervix -
Cancer treatment and survivorship experiences among Southern New Jersey residents.
Protocol: 131803Principal Investigator:
- Sharon Manne PhD (Rutgers University)
Applicable Disease Sites: Colon
Breast - Female
Melanoma, Skin
Ovary
Lung
Rectum
Cervix
Other Female Genital
Thyroid
Prostate
Urinary Bladder -
NCI/CTEP #9892: Phase I Dose-Escalation Bioavailability Study of Oral Triapine in Combination with Concurrent Chemoradiation for Locally Advanced Cervical Cancer (LACC) and Vaginal Cancer.
Protocol: 051909Principal Investigator:
- Eugenia Girda Assistant Professor GYN (Rutgers University)
Applicable Disease Sites: Cervix
Other Female Genital -
NCI/CTEP #9948: Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine with or without M6620 (VX-970) in First Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer.
Protocol: 051912Principal Investigator:
- Eugenia Girda Assistant Professor GYN (Rutgers University)
Applicable Disease Sites: Other Female Genital
Ovary -
A Phase 1b/2, Multicenter, Open-Label Study of DSP-7888 Dosing Emulsion in Combination with Immune Checkpoint Inhibitors Nivolumab or Pembrolizumab in Adult Patients with Advanced Solid Tumors
Protocol: 102004Principal Investigator:
- Eugenia Girda Assistant Professor GYN (Rutgers University)
Applicable Disease Sites: Ovary
Other Female Genital -
ONC-012 : A Phase II Study of ONC201 in Recurrent or Metastatic Type II
Endometrial Cancer.
Protocol: 101702Principal Investigator:
- Eugenia Girda Assistant Professor GYN (Rutgers University)
Applicable Disease Sites: Corpus Uteri
